Acute respiratory distress syndrome and the use of inhaled pulmonary vasodilators in the COVID-19 era: a narrative review
A Nasrullah, S Virk, A Shah, M Jacobs, A Hamza… - Life, 2022 - mdpi.com
The Coronavirus disease (COVID-19) pandemic of 2019 has resulted in significant morbidity
and mortality, especially from severe acute respiratory distress syndrome (ARDS). As of …
and mortality, especially from severe acute respiratory distress syndrome (ARDS). As of …
[HTML][HTML] Inhaled pulmonary vasodilators in severe COVID-19: Don't hold your breath
SS Pawar, ME Wilcox, FMP van Haren - Journal of Critical Care, 2022 - ncbi.nlm.nih.gov
Respiratory failure requiring hospitalisation, oxygen treatment and in severe cases,
mechanical ventilation, is a devastating complication of SARS-CoV-2 infection. Although the …
mechanical ventilation, is a devastating complication of SARS-CoV-2 infection. Although the …
Inhaled pulmonary vasodilators in COVID-19 infection: a systematic review and meta-analysis
Introduction: Inhaled pulmonary vasodilators (IPVD) have been previously studied in
patients with non-coronavirus disease-19 (COVID-19) related acute respiratory distress …
patients with non-coronavirus disease-19 (COVID-19) related acute respiratory distress …
Inhaled pulmonary vasodilator treatment for COVID-19: a systematic review and meta-analysis
PURPOSE: Coronavirus disease 2019 (COVID-19) has become a leading cause of mortality
globally. Inhaled pulmonary vasodilators, epoprostenol (iEPO) and nitric oxide (iNO), are …
globally. Inhaled pulmonary vasodilators, epoprostenol (iEPO) and nitric oxide (iNO), are …
[HTML][HTML] COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment–A narrative review
CA Pfortmueller, T Spinetti, RD Urman… - Best Practice & …, 2021 - Elsevier
Abstract (163 words) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …
Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses—a …
EJ Ragel, LK Harris… - BMJ Open Respiratory …, 2023 - bmjopenrespres.bmj.com
Background Acute respiratory distress syndrome (ARDS) is the most severe form of lung
injury, rendering gaseous exchange insufficient, leading to respiratory failure. Despite over …
injury, rendering gaseous exchange insufficient, leading to respiratory failure. Despite over …
[HTML][HTML] Pharmacological management of COVID-19 patients with ARDS (CARDS): a narrative review
MG Matera, P Rogliani, L Calzetta, M Cazzola - Respiratory medicine, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is highly infectious. It has been highlighted
that if not expertly and individually managed with consideration of the vasocentric features, a …
that if not expertly and individually managed with consideration of the vasocentric features, a …
[HTML][HTML] A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS):“typical” or “atypical” ARDS?
D Pu, X Zhai, Y Zhou, Y Xie, L Tang, L Yin… - Annals of translational …, 2022 - ncbi.nlm.nih.gov
Methods We searched for relevant literature from 1999 to 2021 published in PubMed by
using the following keywords and their combinations:“COVID-19”,“CARDS”,“ARDS”,“ …
using the following keywords and their combinations:“COVID-19”,“CARDS”,“ARDS”,“ …
Compassionate use of pulmonary vasodilators in acute severe hypoxic respiratory failure due to COVID-19
L Matthews, L Baker, M Ferrari… - Journal of Intensive …, 2022 - journals.sagepub.com
Background There have been over 200 million cases and 4.4 million deaths from COVID-19
worldwide. Despite the lack of robust evidence one potential treatment for COVID-19 …
worldwide. Despite the lack of robust evidence one potential treatment for COVID-19 …
Inhaled pulmonary vasodilators are not associated with improved gas exchange in mechanically ventilated patients with COVID-19: a retrospective cohort study
AS Lubinsky, SB Brosnahan, A Lehr, O Elnadoury… - Journal of Critical …, 2022 - Elsevier
Purpose Measure the effect of inhaled pulmonary vasodilators on gas exchange in
mechanically ventilated patients with COVID-19. Methods A retrospective observational …
mechanically ventilated patients with COVID-19. Methods A retrospective observational …